Ovarian cancer is considered the deadliest cancer affecting the female reproductive system. One of the main reasons it is so dangerous is that it is usually discovered very late.
In many patients, doctors do not detect the disease until it has already spread widely across the abdomen. When the cancer reaches this stage, treatment becomes much more difficult and survival rates drop sharply.
For many years, scientists have known that ovarian cancer spreads quickly inside the body, but they did not fully understand why it moves so rapidly. A new study led by researchers at Nagoya University in Japan has now revealed an important piece of the puzzle.
The research, published in the journal Science Advances, shows that ovarian cancer cells do not spread alone. Instead, they recruit help from other cells that normally protect the inside of the abdomen.
Inside the abdominal cavity, the organs are covered by a thin layer of protective cells called mesothelial cells. These cells form a smooth lining that allows organs such as the stomach, liver, and intestines to move easily during breathing and digestion.
Under normal conditions, mesothelial cells act as a protective barrier and help prevent damage to the organs.
The new research shows that ovarian cancer cells take advantage of these protective cells. Instead of invading tissues by themselves, cancer cells recruit mesothelial cells and use them to help create pathways for spreading.
When the two types of cells come together, they form mixed groups known as hybrid cell clusters. These clusters are stronger and more resistant to treatment than cancer cells alone.
To understand how this process works, the researchers studied samples of abdominal fluid taken from patients with ovarian cancer. This fluid, known as ascites, often collects in the abdomen when the disease becomes advanced. Scientists have long believed that cancer cells float freely in this fluid before attaching to other organs.
However, the researchers found something unexpected. Most cancer cells were not floating alone. Instead, they were attached to mesothelial cells, forming compact clusters or spheres made up of both cell types. The team estimated that about 60 percent of these clusters included mesothelial cells that had been recruited by the cancer.
Further investigation revealed how this partnership begins. Ovarian cancer cells release a signaling molecule called TGF‑β1. This molecule acts like a chemical message that alters nearby mesothelial cells.
After receiving the signal, the mesothelial cells change their shape and behavior. They begin forming sharp, spike‑like structures that allow them to cut through surrounding tissue.
As ovarian cancer develops, some cells break away from the original tumor. These cells enter the abdominal cavity and float in the fluid that surrounds the organs. The fluid constantly moves due to breathing and body movement. Because of this movement, the floating cells can travel throughout the abdomen.
This method of spreading is very different from how many other cancers move through the body. In cancers such as breast or lung cancer, tumor cells usually enter blood vessels and travel through the bloodstream. Because blood flows along defined pathways, doctors can sometimes detect and monitor these cancers through blood tests.
Ovarian cancer behaves differently. Instead of entering blood vessels, the cancer cells float freely in abdominal fluid that has no fixed direction. Until now, scientists did not fully understand what happened during this floating stage or how the cancer cells managed to spread so efficiently.
The new study revealed that during this stage the cancer cells actively recruit mesothelial cells that have naturally detached from the abdominal lining. Once they join together, the two cell types form hybrid spheres.
The mesothelial cells then produce special spike‑like structures called invadopodia. These structures act like tiny drills that break through nearby tissue.
When these hybrid clusters reach an organ inside the abdomen, the invadopodia help them invade the tissue quickly. The clusters are also more resistant to chemotherapy drugs than single cancer cells. This combination of faster invasion and stronger drug resistance makes the disease much harder to treat.
The researchers were able to observe this process directly by using advanced microscopy techniques to study patient samples. They also confirmed the findings through experiments in mice and by analyzing gene activity in individual cells.
Lead researcher Dr. Kaname Uno explained that the cancer cells themselves do not change very much. Instead, they manipulate mesothelial cells to perform the difficult work of invading tissue.
The cancer cells then follow the openings created by the mesothelial cells. In this way, the tumor spreads without needing to develop stronger invasive abilities on its own.
Dr. Uno’s interest in this research began during his earlier career as a gynecologist. He treated many patients with ovarian cancer and saw firsthand how quickly the disease could progress.
One patient had normal screening results only three months before doctors discovered advanced ovarian cancer. That experience convinced him that scientists needed to better understand how the disease spreads so rapidly.
The study’s findings may open the door to new treatment strategies. Current chemotherapy treatments are designed to destroy cancer cells. However, they do not target the mesothelial cells that help the cancer spread.
Future treatments might focus on blocking the TGF‑β1 signal that allows cancer cells to recruit these helper cells. Another possible approach would be preventing the formation of the hybrid clusters themselves.
The research also suggests a new way to monitor ovarian cancer. If doctors can detect and track these hybrid clusters in abdominal fluid, they may be able to better predict how quickly the disease is progressing and how well a patient is responding to treatment.
When analyzing the findings of this study, several important points stand out. First, the research highlights how cancer progression often depends on cooperation between different cell types rather than the behavior of tumor cells alone. This broader view of the tumor environment may help scientists discover new treatment targets.
Second, the study emphasizes the importance of early detection. Because ovarian cancer spreads through the abdominal fluid before attaching to organs, detecting these hybrid clusters earlier could potentially improve diagnosis and treatment outcomes.
Finally, while the results are very promising, further research will be needed to confirm how these findings apply to larger patient populations. Future studies may help determine whether blocking the communication between cancer cells and mesothelial cells can effectively slow the disease.
Overall, this discovery provides an important new understanding of why ovarian cancer spreads so quickly. By revealing how cancer cells recruit help from the body’s own protective cells, scientists have uncovered a new possible path toward better treatments and improved survival for patients.
If you care about cancer, please read studies about a new method to treat cancer effectively, and this low-dose, four-drug combo may block cancer spread.
For more information about cancer prevention, please see recent studies about nutrient in fish that can be a poison for cancer, and results showing this daily vitamin is critical to cancer prevention.
Copyright © 2026 Knowridge Science Report. All rights reserved.
